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Exercise is an important determinant of health but is signiﬁcantly reduced in the patient with a univentricular circulation. Normal
exercise physiology mandates an increase in pulmonary artery pressures which places an increased work demand on the right
ventricle (RV). In a biventricular circulation with pathological increases in pulmonary vascular resistance and/or reductions in
RV function, exercise-induced augmentation of cardiac output is limited. Left ventricular preload reserve is dependent upon ﬂow
through the pulmonary circulation and this requires adequate RV performance. In the Fontan patient, the reasons for exercise
intolerance are complex. In those patients with myocardial dysfunction or other pathologies of the circulatory components, it is
likely that these abnormalities serve as a limitation to cardiac performance during exercise. However, in the healthy Fontan patient,
it may be the absence of a sub-pulmonary pump which limits normal increases in pulmonary pressures, trans-pulmonary ﬂow
requirementsandcardiacoutput.Ifso,performancewillbeexquisitelydependentonpulmonaryvascularresistance.Thisprovides
apotentialexplanationastowhypulmonaryvasodilatorsmayimproveexercisetolerance.Ashasrecentlybeendemonstrated,these
agents may oﬀer an important new treatment strategy which directly addresses the physiological limitations in the Fontan patient.
1.Introduction
Exercise is an important determinant of health and provides
numerous cardiovascular, psychological, and prognostic
beneﬁts [1]. The Fontan operation, and its reﬁnements,
have proved a major success with a majority of patients
withuniventricularmalformationsnowsurvivingintoadult-
hood with a good quality of life [2]. However, exercise
tolerance is signiﬁcantly reduced and the factors responsible
for this exertional limitation are incompletely understood.
This paper aims to provide a unique perspective on the
limitations of the Fontan circulation by focusing on exercise
constraintsinanormalbiventricularcirculation.Ratherthan
describing abnormalities within the components of a Fontan
circulation, we will focus on highlighting the importance
of that which is missing—a prepulmonary pump. Popular
models of exercise physiology have concentrated on the
systemiccirculationandtheleftventricle(LV)astheprimary
determinant of cardiac output (CO) augmentation during
physical exertion [3]. These models are likely to be accurate
inpatientswithheartfailure.However,inthehealthysubject,
there is a large reserve for exercise-induced augmentation of
thesystemicventricleandvasculature.Alesscommonlycited
determinant of cardiac performance during exercise is the
“lesser circulation” of the RV and the pulmonary circulation
[4–6]. We will discuss the evidence supporting the concept
that the right ventricle (RV) is a determinant of exercise
performance and that, in its absence, pulmonary vascular
resistance becomes a critical limitation. The recent availabil-
ity of relatively speciﬁc pulmonary vasodilators has given
these physiological discussions immediate clinical relevance.
The potential beneﬁt of these agents [7] is consistent with
physiological theory and represents an exciting avenue of
investigation in Fontan patients.
2. CardiacOutputAugmentationduring
Exercise in the Normal Heart
Exercise performance is deﬁned by the ability of the
body’s working muscles to utilize oxygen, and this can2 International Journal of Pediatrics
be measured by VO2 max on cardiorespiratory testing. It
has been demonstrated that the skeletal muscles’ ability to
utilize oxygen far exceeds the capacity of the cardiovascular
system to deliver oxygen [8]. Thus, cardiac output (CO)
becomes the limiting step, and explains 70%–85% of the
variance in VO2 max with the remainder being determined
by peripheral factors such as mitochondrial density which
enables greater oxygen extraction [9]. In healthy subjects,
CO may be expected to increase 3- to 5-fold whilst increases
are even greater in athletes. Cardiac output is enhanced by
(1) greater preload, (2) increased heart rate, (3) increased
myocardial contractility, and (4) reduced afterload during
exercise,andbothventriclesneedtogeneratethesamestroke
volume. Thus we can speculate as to what is the “weak
link” by asking which factor is closest to its physiological
limit during exercise. Conventional teaching is that it is
the LV and its interaction with the systemic circulation
which determines cardiac output. However, LV functional
measures and measures of systemic vascular tone have not
been shown to predict exercise performance as might be
expected if they were the limitation of exercise performance
[10–12].
2.1. Preload and Exercise. Preload may be deﬁned as the
passive stretch applied to the myocardium prior to the
initiation of active contraction. According to the Frank-
Starling mechanism, increases in preload augment cardiac
output. The extent to which this mechanism contributes
to exercise-induced CO augmentation remains a point of
debate. Studies using radionuclide ventriculography have
reported large increases in LV end-diastolic volume during
exercise and minimal or no decrease in LV end-systolic
volume. Warburton et al. [13, 14] suggested that this
increase in LV preload was the dominant means by which
CO increased during exercise, especially in well-trained
athletes [13, 14]. However, more recent exercise studies
using 2D echocardiography [3, 15–19] and cardiac magnetic
resonance (CMR) [20–22] have found little or no increase
in LV end-diastolic volume and that augmentation of stroke
volume is primarily due to decreases in LV end-systolic
volume. Assimilating these contrasting ﬁndings is diﬃcult,
but perhaps a reasonable summary may be that enhanced
LV preload contributes to, but is not the sole determinant
of, exercise-induced increases in stroke volume.
Accepting the contribution of LV preload in cardiac out-
put augmentation, the question arises as to what determines
LV preload? This is seldom discussed in the literature. It is
oftenassumedthattheLVgeneratesﬂowwhichthenservesas
its own preload with, perhaps, some facilitation fromskeletal
muscle acting to enhance venous return. With a few notable
exceptions [4–6, 23], the RV and pulmonary circulation
have rarely been considered as potential constraints on
LV ﬁlling in normal exercise physiology. We speculate that
its importance may have been underappreciated. At least
in settings where RV afterload is increased, reduced ﬂow
in the presystemic circulation can result in reduced LV
preload and, thus, cardiac output limitation. Holverda et
al. [20, 21] demonstrated reduced LV ﬁlling during exercise
in patients with pulmonary hypertension and obstructive
airways disease. Also, the demonstration of improved exer-
cise tolerance with pulmonary vasodilators provides some
indirect aﬃrmation of this concept. It has been shown that
sildenaﬁl [24, 25] and bosentan [26] can increase exercise
performance at altitude or during hypoxic exercise although
no beneﬁt has been demonstrated in normoxic settings. It
was concluded by Faoro et al. [26] that the pulmonary
circulation provides a limitation to cardiac output when
there is hypoxic pulmonary vasoconstriction. The lack of
eﬃcacyofselectivepulmonaryvasodilatorsduringnormoxic
exercise may suggest that pulmonary vasodilation is close to
maximal in this setting [27].
Frequently, exercise intolerance is attributed to diastolic
dysfunction, and it is implied that the LV ﬁlling impairment
is due to pathology of the LV myocardium. However,
it is important to note that it is extremely diﬃcult to
diﬀerentiate impaired ﬁlling due to myocardial stiﬀness
from that due to reduced preload when using noninvasive
measures[28].Echocardiographicmeasuresaresimilarwhen
there is a lack of “push” from reduced preload and when
there is a lack of “suck” from LV impairment. Puwanant
et al. described reductions in traditional and novel diastolic
measures in patients with pulmonary hypertension despite
relatively normal LV function [28]. Hart et al. reported
measures of diastolic dysfunction which were associated
with preload reduction following marathon running. These
changesnormalizedimmediatelywithpreloadaugmentation
by leg lifting [29]. Finally, in a large cohort of patients
with obstructive pulmonary disease, Barr et al. attributed
impaired LV ﬁlling to preload reduction through increased
pulmonary vascular resistance rather than myocardial stiﬀ-
ness resulting from hypoxia or hypertension [30].
2.2. Afterload and Exercise. Afterload can be deﬁned as the
myocardial stress achieved during contraction, the major
determinants being systolic pressure, cavity size, and wall
thickness [31]. Decreases in LV afterload serve to increase
stroke volume and this has been emphasized as an important
source of cardiac output modulation in popular models
of exercise physiology. It has even been suggested that the
exercise-induced decreases in systemic vascular resistance
(due to vasodilation in skeletal muscle) is the primary deter-
minant of CO augmentation, and that the resultant increases
in heart rate and contractility are simply a compensation
to maintain systemic blood pressures [32, 33]. However, it
has been well established that the capacity for peripheral
vasodilation far exceeds the capacity for cardiac output
augmentation, implying that the limitation to cardiac output
is upstream of the peripheral circulation [34].
Characterization of RV afterload during exercise is
more diﬃcult because its measurement requires invasive
pulmonary artery catheterization or echocardiographic esti-
mates, both of which can be challenging during exercise.
Whilstitiscommonlystatedthatpulmonaryarterypressures
increase only slightly with exercise [35, 36], multiple studies
have reported considerable increases in pulmonary artery
pressures [4, 23, 37–42]. Kovacs et al. [42] combined data
from nearly 200 patients in invasive studies to demonstrate
that mean pulmonary artery pressures increased in a linearInternational Journal of Pediatrics 3
Table 1: Comparison of exercise-induced changes in pulmonary
versus systemic vascular resistance and pressure. The pulmonary
vasculature has very low resistance at rest but relatively lim-
ited capacity for further reduction. Therefore, exercise-induced
increases in ﬂow result in greater pressures due to the inability to
compensate by reducing resistance. As described by the simpliﬁed
Poiseuille’s law: Pressure = Flow × Resistance.
Left Ventricle Right Ventricle
Rest
Cardiac Output (L/min) 5 5
Vascular resistance (dyne-sec·cm5) 1100 70
Afterload Pressure (mmHg) 130/75 (85) 25/9 (15)
Exercise
Cardiac Output (L/min) 25 25
Vascular resistance (dyne-sec·cm5) ↓↓↓ ↓
Afterload Pressure (mmHg) ↑ ↑↑↑
manner with exercise which explains why relatively high
pressures have been measured in those with good exercise
tolerance. Argiento et al. [37] described exercise-induced
increases in systolic pulmonary artery pressures that fre-
quently exceeded 60mmHg in healthy subjects whilst Bidart
et al. [39] reported even greater increases in athletes. It may
be that these increases in pulmonary artery pressures are a
result of an inability for the pulmonary vasculature to reduce
its resistance suﬃciently to compensate for the increased CO
ofexercise.Thisconceptisbestsummarizedbythesimpliﬁed
Poiseuille’s relation in which CO is proportional to pressure
andinverselytoresistance[3].Pulmonaryvascularresistance
is very low at rest and previous studies have suggested that its
capacity for reduction is only 20%–50% [23, 35, 43]. This
represents a marked diﬀerence to the systemic circulation
where greater reductions in peripheral resistance moderate
increases in LV afterload (see Table 1).
2.3. Contractility and Exercise. Contractility is an intrinsic
property of the myocardium, is load independent, and is
most frequently derived from invasive indices such as the
slope of the end-systolic pressure volume relation or the
preload recruitable stroke work [44]. There are no studies
which have assessed and compared LV and RV contractility
during exercise in healthy subjects. At rest, RV measures
of mass [45] and contractility [46] are one-third to one-
ﬁfth those of the LV and this appropriately matches the
pressure requirements of each [47]. However, when RV
afterload increases, RV contractility may be unable to main-
tain ventriculo-arterial coupling such that cardiac output
declines. MacNee [48] described marked reductions in RV
stroke volume (∼30%) when pulmonary artery pressures
doubled and compared this with only slight decreases in LV
stroke volume with physiological increases in mean arterial
pressures. During exercise, Morrison et al. [23] used ﬁrst-
pass radionuclide ventriculography and invasive pressure
measures to demonstrate a progressive improvement in
RV ejection fraction with exercise-induced reductions in
pulmonaryvascularresistance.However,incomparisonwith
the systemic circulation, increases in pulmonary vascular
pressures were relatively greater, and reductions in vascular
resistance were less. This would suggest that exercise results
inadisproportionateworkloadfortheRV,aconceptwhichis
further supported by the demonstration that cardiac fatigue
predominantlyaﬀectstheRVafterintenseprolongedexercise
[49, 50]. Therefore, there are reasonable grounds to contend
that exercise-induced increases in RV load represent a
potential for cardiac output limitation. For cardiac output to
be maintained during exercise, the RV must greatly augment
its contractility, possibly more so than the LV. As will be
discussed, this is problematic for exercise performance when
RV function is reduced or absent.
2.4. Heart Rate and Exercise. Heart rate is a major deter-
minant of cardiac output, particularly in the later phases of
exercisewhenstroke volume augmentationplateaus[3].Itis,
however,ineﬃcientfortheheartratetoincreasesuchthatLV
ﬁlling is impaired. Thus, although the factors which deter-
mine maximal heart rate during exercise are incompletely
understood, it is likely that cardiopulmonary baroreceptor
activation contributes to maintaining an appropriate balance
between LV preload and heart rate during exercise [51].
3. The Healthy Fontan Patientand Exercise:
HowIsReducedExerciseCapacityExplained?
In the Fontan circulation, the systemic and pulmonary
vascular beds are connected in series without the presence
of a pre-pulmonary pump to add forward energy to ﬂow
through the lungs (Figure 1). Typically CO in a Fontan
circulation at rest is decreased to 70% (range 50%–80%)
of normal and an increase in peripheral oxygen utilization
compensates for this reduction in oxygen supply [52].
Duringexercise,oxygenutilizationremainsnormalorsupra-
normalbutmaximalCOisapproximatelyhalfthatofnormal
[53]. Control of cardiac output in a Fontan circulation is
complex with a diﬀerent interplay of contractility, afterload,
preload, and heart rate [54]. The implications of exercise on
each of these variables will be discussed and contrasted with
that already described for normal subjects.
3.1. Preload and Exercise in the Fontan Patient. There is
limited data in which LV ﬁlling during exercise has been
assessed in the Fontan patient. More frequently, studies have
assessedthehemodynamicresponsetolow-dosedobutamine
as an exercise surrogate. Senzaki et al. [55, 56]h a v e
twice demonstrated limitations in preload reserve in this
setting. They demonstrated a signiﬁcant 25% reduction in
LV end-diastolic pressure in the Fontan patient whereas
t h e r ew a sn oc h a n g ei ns u b j e c t sw i t hn o r m a lc i r c u l a t i o n
[56]. Using variables derived from ventricular pressure-area
hybrid loops, they found that cardiac index was dependent
upon preload (end-diastolic area) and not contractility
(ventricular elastance) or afterload (arterial elastance). Thus,
inadequate preload reserve was implicated in the failure for
CO to augment with β-adrenergic stimulation. Robbers-
Visser et al. [57] used CMR imaging to provide a volumetric
assessment of dobutamine-induced cardiac augmentation in4 International Journal of Pediatrics
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Figure 1: Theoretical schema to illustrate circulatory pressure changes in normal and Fontan patients at rest and during exercise. In the
normal circulation, pressure is generated in the systemic ventricle (LV) to produce ﬂow in the aorta (Ao) and systemic circulation (S).
Pressure dissipates across the systemic microcirculation such that right atrial (RA) pressures are low. The pre-pulmonary pump (RV)
provides the pressure to generate the ﬂow in the pulmonary artery (PA) which then dissipates in the pulmonary circulation (P) but is
suﬃcient to maintain preload in the left atrium (LA). During exercise, systemic vascular resistance falls such that there is little increase in
mean LV pressure requirements. However, more substantial pressure increases are required in the RV (purple arrow), and these pressure
requirements increase with exercise intensity. In the Fontan patient (below), the cavopulmonary bypass (CPB) does not provide any
contractile force and, therefore, ﬂow through the pulmonary circulation is dependent on the pressure diﬀerence between the RA and LA.
During exercise, trans-pulmonary ﬂow can only be augmented by reductions in pulmonary vascular resistance. Beyond mild to moderate
exercise, pulmonary vasodilation is maximal and ﬂow increases require a pre-pulmonary pump. Without this, pulmonary pressure does
not rise, trans-pulmonary ﬂow does not increase, LA pressure (preload) does not increase, and cardiac output cannot supply the metabolic
demands of exercise.
a young group of patients with Fontan circulation. They
described a modest increase in CO which was entirely due
to increasing heart rate. Stroke volume was unchanged due
to the fact that end-diastolic volumes decreased to the
same extent as end-systolic volumes. This contrasts with
the normal physiological response to dobutamine in which
stroke volume increases due to a reduction in end-systolic
volume and preserved end-diastolic volumes [58, 59]. Thus,
CO limitation in the Fontan patient was again attributed to
inadequate preload reserve suggesting that the constraint to
exercise is “up-stream” of the LV.
As discussed previously, measures of impaired ﬁlling
should not be regarded as synonymous with LV pathology.
Preload reduction and myocardial relaxation impairment
will manifest similarly on non-invasive measures such as
echocardiography. This is well illustrated in a recent study
performed by Goldstein et al. [60] in which echocardio-
graphic indices of diastolic dysfunction were demonstrable
in 16 of 28 young Fontan patients. However, hemodynamic
data performed in a subset of these patients during exercise
demonstrated normal LV ﬁlling pressures which did not
increase with exercise, a ﬁnding which is inconsistent with
the raised ﬁlling pressures expected with diastolic dysfunc-
tion [61, 62]. Rather, these ﬁndings again reinforce the
concept of preload inadequacy whereby the normal exercise-
induced augmentation in LV ﬁlling pressures [42]i sa b s e n t
in the Fontan patient.
3.2. Afterload and Exercise in the Fontan Patient. In the
Fontan patient during exercise, the reduction in systemic
vascular resistance is less than in the normal subject [52]. It
is likely that this represents a secondary phenomenon which
attemptstomaintainbloodpressurewhenCOaugmentation
is reduced. This is achieved by an increase in sympathetic
vasomotor tone [63] but is not always suﬃcient and BP may
still fall in the Fontan patient during exercise [52]. Thus the
relatively greater systemic afterload in the Fontan patient is a
consequence, rather than cause, of reduced output.
As described earlier, normal exercise is associated with an
increase in stroke volume and pulmonary artery pressures.
A pre-pulmonary pump is required to generate the pressure
and ﬂow which enables adequate LV ﬁlling during exercise.
Without a pre-pulmonary pump, and without adequate
preload, cardiac output cannot increase during exercise.
Figure 1 provides a graphic summary of this proposed
physiology.
Indirectevidenceforourpropositionthatthepulmonary
circulation serves as a limitation to exercise in the FontanInternational Journal of Pediatrics 5
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Figure 2: Relationship of output during exercise, pulmonary
vascular resistance (PVR), and ventricular function. Cardiac output
can increase 5-fold in a normal (N) subject with a biventricular
circuit. If ventricular function is impaired, this will ﬁrst result in
decreased maximal output and subsequently in reduced output
at low level of exercise. In Fontan patients (F) output is more
inﬂuenced by PVR than by ventricular function but all have
signiﬁcantly impaired exercise capacity. EF: ejection fraction.
patient is provided by the demonstration that exercise
tolerance is improved with pulmonary vasodilators. Giardini
et al. [7] studied the exercise response in 18 Fontan
patients before and after a single oral dose of sildenaﬁl
as compared with a group of 9 control Fontan patients.
An improvement in VO2 max (9.4 ± 5.2%) and cardiac
index (10.0 ± 7.2%) was demonstrable in those who took
sildenaﬁlwhilstthesemeasureswereunchangedinthosewho
did not receive treatment. Pulmonary vasodilator therapy
warrants further investigation in Fontan patients given
its potential to address a likely source of limitation to
exercise.
3.3. Contractility and Exercise in the Fontan Patient. There
is limited evidence to suggest that contractility serves
as a limitation to CO in the Fontan patient, with the
exception of those patients with advanced ventricular dys-
function [54]. As described earlier, Senzaki et al. [55]
used hybrid measures of ventricular elastance to demon-
strate that contractility and contractile reserve were largely
preserved in the Fontan patient. Studies that have sug-
gested reduced systolic performance in the Fontan ventricle
have frequently based conclusions on measures which are
load dependent [64]. Furthermore, if abnormalities of the
systemic ventricle and the peripheral circulation were a
cause of exercise limitation, a beneﬁt in exercise tolerance
might be expected with ACE inhibitor therapy but this
has not been demonstrated [65]. Figure 2 summarizes
the relative contribution of LV function and pulmonary
vascular resistance to exercise-induced increases in cardiac
output.
3.4. Heart Rate and Exercise in the Fontan Patient. In
the Fontan patient, atrial pacing at increased rates does
not result in the augmentation of cardiac output that is
seen in normal subjects. Rather, there is a proportional
reduction in stroke volume which illustrates heart rate has
a less direct eﬀe c to nC Ot h a ni nan o r m a lc i r c u l a t i o n
[66]. During exercise, Fontan patients exhibit chronotropic
incompetence with a heart rate consistently lower than
normal controls, and this has typically been attributed
to abnormal reﬂex control of heart rate or adrenergic
dysfunction [67–71]. However, preload inadequacy in the
Fontan patient may lead to reducing stroke volume if the
ventricular ﬁlling time decreases with increasing heart rate.
Thus, it is possible that chronotropic incompetence is an
adaptive response to prevent hemodynamic compromise in
patients with limited preload, such as in the Fontan patient
[72, 73].
4. Summary
Traditional models of exercise physiology have emphasized
the performance of the systemic ventricle and systemic
circulation. In the Fontan patient with pathology of the
systemic ventricle, these abnormalities will largely explain
exercise limitation. However, in the healthy Fontan patient,
limitation is deﬁned by upstream factors which determine
systemic ventricular ﬁlling. Inadequate preload reserve has
been demonstrated to limit cardiac augmentation caused by
ionotropic stimulation and it is likely that this mechanism
also explains cardiac limitation during exercise. At rest,
pulmonary vascular resistance and pressure are low. During
exercise, increases in ﬂow mandate an increase in pressure
unless resistance can fall proportionately. Substantial reserve
in the systemic circulation moderates pressure increases
whilst, in the pulmonary circulation, there is evidence that
the capacity for further vasodilation is limited. In a normal
biventricular circulation, this results in greater pressure and
work demands for the RV during exercise. However, in the
Fontan patient, there is no RV to provide this work demand
and hence ﬂow, LV ﬁlling and CO are unable to increase
normally.
This discussion of Fontan physiology has important
clinical implications. Treatment regimens are most likely to
beeﬃcaciousiftheyaddressthepartofthecirculationwhich
serves as the greatest source of limitation. Classical heart
f a i l u r er e g i m e n sh a v ed e m o n s t r a t e dp o o re ﬃcacy in Fontan
patients but this may be expected if the systemic circulation
is not the primary source of limitation. Selective pulmonary
vasodilators target a potential “weak link” in the Fontan
circuit. Early results with these agents have oﬀered promise
and may prove an important means of improving exercise
tolerance.
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